Boettger Michael K, Hensellek Susanne, Richter Frank, Gajda Mieczyslaw, Stöckigt Renate, von Banchet Gisela Segond, Bräuer Rolf, Schaible Hans-Georg
University Hospital of Jena, Jena, Germany.
Arthritis Rheum. 2008 Aug;58(8):2368-78. doi: 10.1002/art.23608.
The reduction of pain in the course of antiinflammatory therapy can result from an attenuation of the inflammatory process and/or from the neutralization of endogenous mediators of inflammation that act directly on nociceptive neurons. The purpose of this study was to investigate whether analgesic effects of the neutralization of tumor necrosis factor alpha (TNFalpha) are due to an attenuation of inflammation or whether direct neuronal effects significantly contribute to pain relief in the course of therapy.
Locomotor and pain-related behavior and histology were assessed in rats with chronic antigen-induced arthritis (AIA) in the knee joint, and the rats were treated with systemic saline, etanercept, or infliximab. The expression of TNF receptors (TNFRs) in dorsal root ganglia was measured using immunohistochemical analysis and polymerase chain reaction. Action potentials were recorded from afferent Adelta fibers and C fibers of the medial knee joint nerve, and etanercept and infliximab were injected intraarticularly into normal or inflamed knee joints (AIA or kaolin/carrageenan-induced inflammation).
In rats with AIA, both etanercept and infliximab significantly decreased inflammation-induced locomotor and pain-related behavior, while joint swelling was only weakly attenuated and histomorphology still revealed pronounced inflammation. A large proportion of dorsal root ganglion neurons showed TNFRI- and TNFRII-like immunoreactivity. Intraarticular injection of etanercept reduced the responses of joint afferents to mechanical stimulation of the inflamed joint starting 30 minutes after injection, but had no effect on responses to mechanical stimulation of the uninflamed joint.
Overall, these data show the pronounced antinociceptive effects of TNFalpha neutralization, thus suggesting that reduction of the effects of TNFalpha on pain fibers themselves significantly contributes to pain relief.
抗炎治疗过程中疼痛减轻可能是由于炎症过程的减弱和/或直接作用于伤害性神经元的内源性炎症介质的中和。本研究的目的是调查肿瘤坏死因子α(TNFα)中和的镇痛作用是由于炎症的减弱,还是直接的神经元效应在治疗过程中对疼痛缓解有显著贡献。
对膝关节慢性抗原诱导性关节炎(AIA)大鼠的运动和疼痛相关行为以及组织学进行评估,大鼠分别接受全身生理盐水、依那西普或英夫利昔单抗治疗。使用免疫组织化学分析和聚合酶链反应测量背根神经节中TNF受体(TNFRs)的表达。记录内侧膝关节神经传入Aδ纤维和C纤维的动作电位,并将依那西普和英夫利昔单抗关节内注射到正常或发炎的膝关节(AIA或高岭土/角叉菜胶诱导的炎症)中。
在AIA大鼠中,依那西普和英夫利昔单抗均显著降低了炎症诱导的运动和疼痛相关行为,而关节肿胀仅略有减轻,组织形态学仍显示明显炎症。大部分背根神经节神经元显示出TNFRI和TNFRII样免疫反应性。关节内注射依那西普可降低关节传入神经对发炎关节机械刺激的反应,注射后30分钟开始起效,但对未发炎关节的机械刺激反应无影响。
总体而言,这些数据显示了TNFα中和的显著抗伤害感受作用,因此表明降低TNFα对疼痛纤维本身的作用对疼痛缓解有显著贡献。